A Whistle-Stop Tour of 2017 – From An EU Regulatory Point Of View
Executive Summary
This past year was a busy one for regulators and regulated alike in the EU. We take a look at some of the key events from 2017.
You may also be interested in...
Pharma Struggling To Assimilate Flood Of Clinical Trial Data
Big data may be prolonging development times for new pharmaceuticals, as companies struggle to cope with diverse digital applications and clinical trial protocol changes.
EMA Ends Year With Set of Straight Noes For PRIME Applicants
The European Medicines Agency rejected all seven eligibility requests for its priority medicines scheme that it reviewed in December.
Enhanced EudraVigilance System Goes Live, EMA Updates Info For Users
After months of preparations, the European Medicines Agency’s improved pharmacovigilance database has gone live on schedule.